|
Contraceptives, Oral, Synthetic
|
D27.505.954.705.360.276.210.443 |
|
|
Insurance Carriers
|
N03.219.521.576.160 |
|
|
Tinea Pedis
|
C23.888.885.625.500 |
|
|
Pruritus
|
C23.888.885.625 |
|
|
Decision Making, Shared
|
I03.743.500 |
|
|
Stakeholder Participation
|
I03.743 |
|
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11
|
D054592 |
[A subtype of non-receptor protein tyrosine phosphatases that contain two SRC HOMOLOGY DOMAINS. Mutations in the gene for protein tyrosine phosphatase, non-receptor type 11 are associated with NOONAN SYNDROME.
] |
|
Thiabendazole
|
D02.886.675.840 |
|
|
Protein Tyrosine Phosphatase, Non-Receptor Type 4
|
D054590 |
[A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an amino-terminal FERM domain, an intervening region containing one or more PDZ domains, and a carboxyl-terminal phosphatase domain. The subtype was originally identified in a cell line derived from MEGAKARYOCYTES.
] |
|
Protein Tyrosine Phosphatase, Non-Receptor Type 13
|
D054595 |
[A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an amino-terminal FERM domain, an intervening region containing five different PDZ domains, and a carboxyl-terminal phosphatase domain. In addition to playing a role as a regulator of the FAS RECEPTOR activity this subtype interacts via its PDZ and FERM domains with a variety of INTRACELLULAR SIGNALING PROTEINS and CYTOSKELETAL PROTEINS.
] |
|
Caulobacter
|
B03.440.400.280 |
|
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22
|
D054596 |
[A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an N-terminal catalytic domain and a C-terminal PROLINE-rich domain. The phosphatase subtype is predominantly expressed in LYMPHOCYTES and plays a key role in the inhibition of downstream T-LYMPHOCYTE activation. Polymorphisms in the gene that encodes this phosphatase subtype are associated with a variety of AUTOIMMUNE DISEASES.
, An alternatively spliced variant of tyrosine protein phosphatase, non-receptor type 22.
] |
|
SH2 Domain-Containing Protein Tyrosine Phosphatases
|
D054593 |
[A subcategory of protein tyrosine phosphatases that contain SH2 type SRC HOMOLOGY DOMAINS. Many of the proteins in this class are recruited to specific cellular targets such as a cell surface receptor complexes via their SH2 domain.
] |
|
Flurandrenolone
|
D04.210.500.745.745.654.473 |
|
|
Protein Tyrosine Phosphatase, Non-Receptor Type 12
|
D054594 |
[A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of a N-terminal catalytic domain and a large C-terminal domain that is enriched in PROLINE, GLUTAMIC ACID, SERINE, and THREONINE residues (PEST sequences). The phosphatase subtype is ubiquitously expressed and implicated in the regulation of a variety of biological processes such as CELL MOVEMENT; CYTOKINESIS; focal adhesion disassembly; and LYMPHOCYTE ACTIVATION.
] |
|
Sweat
|
A12.200.849 |
|
|
Review
|
V02.600.500 |
|
|
Journal Article
|
V02.600 |
|
|
Disaster Medicine
|
D054597 |
[Branch of medicine involved with management and organization of public health response to disasters and major events including the special health and medical needs of a community in a disaster.
] |
|
Dictionaries, Medical as Topic
|
L01.178.682.192.836.285.419 |
|
